Saudi Arabia Home Infusion Therapy Market

Market Overview:

The Saudi Arabia home infusion therapy market size reached USD 401.0 Million in 2024. The market is projected to reach USD 1,933.0 Million by 2033, exhibiting a growth rate (CAGR) of 17.5% during 2025-2033. The rapidly aging population, patient preference for home-based care, favorable government support, technological advancements, chronic disease prevalence, cost-efficiency offered by the service, and skilled healthcare workforce represent some of the key factors driving the market.

Home infusion therapy is a specialized healthcare service that allows patients to receive intravenous (IV) medications, fluids, and other treatments in the comfort of their homes. This form of treatment is typically prescribed for individuals with various medical conditions, such as infections, autoimmune disorders, chronic illnesses, or those who require long-term medication regimens. Home infusion therapy offers several advantages, including convenience, reduced hospital stays, and improved patient quality of life. Patients undergoing home infusion therapy work closely with a team of healthcare professionals, including registered nurses and pharmacists, who ensure the safe and effective administration of medications through an IV line. The process begins with a thorough assessment of the medical needs of the patient, followed by the preparation and delivery of the necessary medications and supplies to the home of the patient. Nurses provide comprehensive education on self-care, monitoring, and any potential side effects, empowering patients to actively participate in their treatment.

Key Trends of Saudi Arabia Home Infusion Therapy Market:

High incidence of chronic diseases

Increasing prevalence of chronic diseases is propelling the market growth. Conditions, such as hypertension, diabetes, cancer, heart failure, and autoimmune disorders, often require regular infusions of medication, fluids, and nutrients. In October 2024, a study was conducted to assess the incidence of hypertension and its related risk factors within the population of Saudi Arabia's Northern Region. A total of 101 (16%) participants in the study were found to have hypertension. The need for safe, practical, and affordable treatment options is growing as more people receive these diagnoses. By enabling patients to receive care in a comfortable environment, home infusion therapy lowers the risk of infection and hospitalization. Additionally, it promotes improved illness management and increases patient compliance with treatment regimens. Families and healthcare professionals are searching for adaptable solutions as chronic diseases are on the rise as a result of lifestyle changes. Home-based infusion services are becoming a crucial component of the healthcare system as a result of this development.

Rising government support for home healthcare

The growing government support for home healthcare is offering a favorable market outlook. Under Vision 2030, the government is promoting healthcare models that improve patient quality of life and reduce pressure on hospitals. This includes funding programs, licensing private home care providers, and investing in training for home healthcare professionals. As part of this support, authorities are implementing policies that allow more treatments, such as infusion therapy, to be safely delivered at home. These initiatives help build trust in home care and increase access across different regions. By supporting the expansion of home healthcare infrastructure and services, the government is creating a strong foundation for home infusion therapy to broaden. This is making it easier for patients to receive needed care in a more comfortable and cost-effective setting. Rising investments in healthcare are strengthening the market growth. As per industry reports, from 2020 to 2024, Saudi entities allocated more than USD 6.47 Billion to local healthcare projects, indicating a strong national commitment to increasing hospital capacity, enhancing diagnostics, and fostering technology-oriented care.

Increasing aging population

Rising aging population is propelling the market growth. Older adults are more likely to suffer from chronic conditions, which often require regular infusion treatments. Many elderly patients prefer receiving care at home to avoid the stress of traveling to hospitals and remain in a familiar environment. Home infusion therapy offers comfort, safety, and reduced exposure to hospital-acquired infections. As the population is aging, families and caregivers are also seeking solutions that support independent living while ensuring proper medical attention. This shift in care preferences is leading to greater acceptance of home-based services. The growing number of elderly patients needing frequent treatments is making home infusion therapy an essential and expanding part of the healthcare system in Saudi Arabia. As per the UNFPA, Saudi Arabia is experiencing a demographic shift, with the population aged 60 and above projected to rise five times from 2 Million (5.9% of the total population) in 2020 to 10.5 Million (23.7%) by 2050.

Growth Drivers of Saudi Arabia Home Infusion Therapy Market:

Advancements in infusion technology

Advancements in infusion technology have made treatments safer, easier, and more accessible for patients at home. Modern infusion devices are more compact, portable, and user-friendly, allowing patients and caregivers to operate them with minimal training. These technologies include smart pumps, wearable infusion devices, and remote monitoring systems that improve treatment accuracy and reduce the risk of complications. As technology is improving, patients can receive complex therapies, such as antibiotics, chemotherapy, and nutrition support, without needing hospital visits. Real-time data tracking also allows healthcare providers to monitor progress and adjust treatments remotely. These innovations increase confidence in home-based care and support broader adoption of infusion therapy at home. Consequently, technology is becoming a key enabler of safer and more efficient healthcare delivery outside traditional clinical settings.

Insurance and reimbursement developments

Insurance and reimbursement developments are positively influencing the market. As insurance providers begin to cover home-based treatments, more patients can choose infusion therapy at home instead of in hospitals. Improved reimbursement policies reduce the out-of-pocket burden on families and encourage healthcare providers to offer home infusion services. This shift is facilitating cost-effective care while maintaining quality and safety. With better coverage, patients are more likely to adhere to long-term treatment plans, improving health outcomes. Insurers also see value in promoting home care, as it lowers hospitalization costs and minimizes readmission rates. As the insurance system is evolving to support modern care models, it is fueling the growth of the home infusion therapy market across the country.

Growing overcrowding in hospitals

Rising overcrowding in hospitals and the need for better capacity management are stimulating the market growth. As hospitals are experiencing high patient volumes, especially those needing long-term treatment, home infusion offers a practical solution to free up beds and resources. By moving stable patients out of inpatient settings, hospitals can focus on critical and emergency cases. Home infusion therapy allows patients to receive necessary treatments like antibiotics, hydration, and nutrition support without occupying hospital space. This improves overall system efficiency and reduces wait times. Healthcare planners are recognizing the benefits of decentralized care models in managing capacity, making home-based services an essential part of healthcare strategy. Consequently, the demand for home infusion therapy continues to rise in response to overcrowding challenges.

Saudi Arabia Home Infusion Therapy Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the country level for 2025-2033. Our report has categorized the market based on product and application.

Product Insights:

• Infusion Pumps
• Intravenous Sets
• IV Cannulas
• Needleless Connectors

The report has provided a detailed breakup and analysis of the market based on the product. This includes infusion pumps, intravenous sets, IV cannulas, and needleless connectors.

Application Insights:

• Anti-Infective
• Endocrinology
  • Diabetes
  • Others
• Hydration Therapy
  • Athletes
  • Others
• Chemotherapy
• Enteral Nutrition
• Parenteral Nutrition
• Specialty Pharmaceuticals     
• Others

A detailed breakup and analysis of the market based on the application have also been provided in the report. This includes anti-infective, endocrinology (diabetes and others), hydration therapy (athletes and others), chemotherapy, enteral nutrition, parenteral nutrition, specialty pharmaceuticals, and others.

Regional Insights:

• Northern and Central Region
• Western Region
• Eastern Region
• Southern Region

The report has also provided a comprehensive analysis of all the major regional markets, which include Northern and Central Region, Western Region, Eastern Region, and Southern Region.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Saudi Arabia Home Infusion Therapy Market News:

• January 2025: The Ministry of Health, via health clusters, revealed plans to offer home healthcare services across the Kingdom, focusing on enhancing living quality, patient experience, and offering all-encompassing treatment solutions. The ministry indicated that essential home care services encompassed wound and bed sore management, chronic illness follow-ups, home visits, post-surgical care, dental and oral health, and intravenous therapy.
• September 2024: Research was conducted to assess the condition of recognized but unaddressed patients with Fabry Disease (FD), and the challenges in diagnosing and treating FD within the Kingdom of Saudi Arabia (KSA). The experts tackled the stigma associated with FD, patient comprehension and awareness, genetic testing, biomarkers, and at-home infusion therapy. Studies done with patients and nurses involved in home healthcare for those with Gaucher disease, FD, and mucopolysaccharidosis II showed an adherence rate of 92.9% and an enhancement in quality of life (QoL) of 88.5%. 77% of patients indicated that they felt at ease with the treatment.

Saudi Arabia Home Infusion Therapy Market Report Coverage:

Key Benefits for Stakeholders:

• IMARC’s industry report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the Saudi Arabia home infusion therapy market from 2019-2033.
• The research report provides the latest information on the market drivers, challenges, and opportunities in the Saudi Arabia home infusion therapy market.
• Porter's five forces analysis assist stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the Saudi Arabia home infusion therapy industry and its attractiveness.
• Competitive landscape allows stakeholders to understand their competitive environment and provides an insight into the current positions of key players in the market.